Description

Certara Inc.: Is The Software Revenue & Bookings Growth Here To Stay? 

Certara’s performance in the first quarter of 2025 shows a blend of favorable developments and continuing challenges, reflecting its position in the dynamic pharmaceutical and biosimulation market. The company reported revenue of $106 million, which marks a 10% growth compared to the previous year. This growth is complemented by a 12% increase in bookings, amounting to $118.2 million, with notable contributions from software bookings, which grew by 23%.

Our Report Structure:

⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures

Want unlimited access to our reports? Purchase our $99 annual subscription!